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Actinins are strain-sensing actin cross-linkers that are ubiquitously expressed and harbor mutations in hu-
man diseases. We utilize CRISPR, pluripotent stem cells, and BioID to study actinin interactomes in human
cardiomyocytes. We identify 324 actinin proximity partners, including those that are dependent on sarco-
mere assembly. We confirm 19 known interactors and identify a network of RNA-binding proteins, including
those with RNA localization functions. In vivo and biochemical interaction studies support that IGF2BP2 lo-
calizes electron transport chain transcripts to actinin neighborhoods through interactions between its K ho-
mology (KH) domain and actinin’s rod domain.We combine alanine scanningmutagenesis andmetabolic as-
says to disrupt and functionally interrogate actinin-IGF2BP2 interactions, which reveal an essential role in
metabolic responses to pathological sarcomere activation using a hypertrophic cardiomyopathy model.
This study expands our functional knowledge of actinin, uncovers sarcomere interaction partners, and re-
veals sarcomere crosstalk with IGF2BP2 for metabolic adaptation relevant to human disease.
INTRODUCTION
Actinin proteins are ubiquitous spectrin family members that
cross-link actin and are important for myriad cell functions,
including adhesion, migration, contraction, and signaling (Liem,
2016). The four human actinin isoforms have distinct expression
profiles (non-muscle ACTN1 and ACTN4, cardiac muscle
ACTN2, and skeletal muscle ACTN3) but share homologous
amino acid sequences that are organized into three structural
domains: an actin-binding (AB) domain composed of two calpo-
nin-homology domains, a central rod domain containing four
spectrin-like repeats (SRs), and a calmodulin-like domain
(CaM) (Ribeiro et al., 2014). While it is thought that actinin
evolved initially to regulate the early eukaryotic actin-based cyto-
skeleton (Virel and Backman, 2004), it has acquired more elabo-
rate functions in vertebrates, including a mechanical role in the
sarcomere, a specialized contractile system required for striated
muscle function (Murphy and Young, 2015; Virel and Backman,
2004). Moreover, normal actinin function is important for multiple
human organ systems as inheritance of ACTN1, ACTN2, and
ACTN4 mutations have also been linked to congenital macro-
thrombocytopenia, hypertrophic cardiomyopathy (HCM), and
focal segmental glomerulosclerosis of the kidney, respectively
(Chiu et al., 2010; Kaplan et al., 2000; Kunishima et al., 2013).
In the cardiac sarcomere, alpha-actinin-2 (referred henceforth
as actinin) is a major structural component of the Z-disk, where it
is essential for sarcomere assembly and function (Chopra et al.,
2018). Actinin regulates sarcomere assembly by providing a
scaffold for protein-protein interactions (PPIs) such as with titin
(TTN) and actin through CaM and AB domains, respectively
(Chopra et al., 2018; Grison et al., 2017; Schultheiss et al.,
1992). Secondary to these interactions, the thin and thick fila-
ment sarcomere structures are organized to promote twitch
contraction. It has also been observed that while the Z-disk is
one of the stiffest sarcomere structures, actinin demonstrates
remarkably dynamic and complex molecular interactions (such
as with the actin cytoskeleton) that are necessary for normal my-
ocyte function (Sanger and Sanger, 2008). Moreover, actinin
interaction partners have also been described to exit the sarco-
mere to execute critical roles in cell signaling, protein homeosta-
sis, and transcriptional regulation (Lange et al., 2006). Secondary
to the vast repertoire and dynamics of actinin molecular interac-
tions, there remain extensive gaps in our knowledge of not only
how actinin regulates sarcomere assembly and function but also
within other cellular contexts enriched for actinin expression
such as at focal adhesions in both striated and non-striated cells
that may inform how actinin mutations cause human disease
(Djinovic-Carugo et al., 2002; Foley and Young, 2014).
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Figure 1. BioID to identify actinin proximity partners through sarcomere assembly
(A) Overview of actinin localization in cardiomyocytes including sarcomere Z-disk, focal adhesion, and cortical actin cytoskeleton.
(B) Overview of the BioID method using Actinin-BirA* fusion to study actinin-proximal protein networks.
(C) Actinin-BirA* and control non-BirA* iPSC-CM lysates were probed with anti-actinin and anti-GAPDH antibodies to identify (left) and quantify (right) Actinin-
BirA* fusion (~130 kD) and endogenous actinin (~100 kD).
(D) Actinin-BirA* cardiac microtissues have similar twitch force compared to non-BirA* controls (n = 12–15) (scale bar, 150 mm).
(legend continued on next page)




Here, we studied the actinin proximity interactome in CRISPR-
engineered human cardiomyocytes using proximity-dependent
biotinylation (BioID) (Roux et al., 2012). Our study employs
induced pluripotent stem cell cardiomyocytes (iPSC-CMs) differ-
entiated from human iPSCs that express actinin fused to the pro-
miscuous biotinylating enzyme BirA* from the endogenous
ACTN2 locus to provide physiological actinin expression levels
and regulation. We identify 324 actinin proximity partners,
including those that are dynamically regulated by sarcomere as-
sembly, to reveal molecular insights into this process. Our study
uncovers actinin interaction partners, including the RNA-binding
protein IGF2BP2, which we observe to function in electron trans-
port chain (ETC) transcript localization to actinin neighborhoods.
Disruption of actinin-IGF2BP2 interactions revealed an essential
role in metabolic adaptation to pathological sarcomere activa-
tion induced by an HCM mutation. Our study also provides a
compendium of proteins that can be studied to reveal insights
into sarcomere dynamics and other actinin functions.
RESULTS
BioID to identify actinin proximity partners through
sarcomere assembly
Actinin is an integral member of the actin cytoskeleton, where it
interacts within multiprotein complexes such as Z-disks and
focal adhesions (Figure 1A). To study actinin interactions, we uti-
lized BioID (Gingras et al., 2019), which is a proximity-dependent
tagging method using BirA*, a modified version of E. coli BirA
that exhibits promiscuous lysine biotinylation within a 10 nm
radius of expression (Figure 1B; Kim et al., 2014). Using CRISPR,
we fused BirA* with a hemagglutinin (HA) tag to the C terminus of
endogenous ACTN2 (Actinin-BirA*) in a human iPSC line (Fig-
ure S1A). Following differentiation to iPSC-CMs, expression
levels of Actinin-BirA* fusion protein was similar to unmodified
control iPSC-CMs that do no express Actinin-BirA* (non-BirA*)
(Figure 1C). To verify that Actinin-BirA* functioned similarly to un-
modified actinin, we utilized a cardiac microtissue (CMT) assay
previously applied to study sarcomere mutations that cause
heart failure (Cohn et al., 2019; Hinson et al., 2015). CMT twitch
force was unaltered by Actinin-BirA* expression (Figure 1D;
Video S1). We next verified localization of Actinin-BirA* to the
Z-disk by both colocalization immunofluorescence (Figures 1E
and S1B) and HA immunoprecipitation (Figure S1C) that demon-
strated Actinin-BirA* pulled down with the Z-disk protein TCAP
(Hayashi et al., 2004), but not theM-line protein myomesin (Auer-
bach et al., 1999). We observed that 50 mM biotin supplementa-
tion provided strong biotinylation signal in lysates obtained from
Actinin-BirA* cells (Figures 1F and S1D), and biotinylated targets
overlapped actinin (Figure 1E). Finally, we observed negligible
biotinylation in biotin-pulsed wild-type (WT) control iPSC-CMs
that do not express BirA* (Figure 1G).
To identify actinin proximity partners, we subjected both
biotin-pulsed Actinin-BirA* and control non-BirA* iPSC-CM ly-
sates to streptavidin immunoprecipitation followed by tandem
mass tag (TMT) quantitative proteomics (Table S1). Analysis
of Actinin-BirA* versus control non-BirA* samples identified
enrichment of 324 actinin proximity partners (log2 fold change
[L2FC] R 1 and false discovery rate [FDR] < 0.05; Figure 1H;
Table S1). We confirmed 38% of previously known actinin
interactors using Search Tool for the Retrieval of Interacting
Genes/Proteins (STRING) (Szklarczyk et al., 2019; Figure 1I).
Gene Ontology (GO) analysis of interactors revealed functions
in cell adhesion, anchoring junction, actin cytoskeleton, contrac-
tile fiber, and RNA binding (Figure 1J; Table S1).
Z-disks develop from punctate Z-body precursors (Du et al.,
2003), but the actinin interactions underlying this process are
incompletely understood. To identify actinin neighborhoods un-
derlying this transition, into Actinin-BirA* iPSCs, we knocked
out cardiac troponin T (cTnT-KO; Figure S1E), because cTnT-
KO iPSC-CMs assembly only Z-bodies unless cTnT is reintro-
duced by lentiviral transduction as described previously (Petti-
nato et al., 2020). After confirming that biotin-pulsed cTnT-KO
and cTnT-WT iPSC-CMs exhibited the expected biotinylation
of proteins overlapping Z-body and Z-disk structures (Fig-
ure S1F), respectively, we then performed TMT (Figure S1G;
Table S1). We identified 24 actinin neighborhood proteins that
were exclusively enriched in the Z-disk stage (L2FC R 1 and
FDR < 0.05; Table S1), which were significant for GO terms,
including RNA binding, anchoring junction, and cadherin bind-
ing (Figure S1I; Table S1). Only SPHKAP, a membrane-
anchoring protein associated with heart failure (Aye et al.,
2012), was exclusive to Z-bodies. In addition, we identified 47
proteins that were more highly enriched in Z-disk relative to
Z-body stages as defined by relative abundancies in cTnT-
WT compared to cTnT-KO samples (L2FC R 1 and FDR <
0.05; Table S1), which were enriched for GO terms, including
contractile fiber and actin cytoskeleton (Figure S1J; Table
S1). Among the 47 (Figure S1K), we observed that a muscle
myosin (MYH7), as previously described (Rode et al., 2016),
was one of the most highly enriched proteins in Z-disk relative
to Z-body stages (Figure S1K), while non-muscle myosin
(MYH10) was similar in both stages. In addition, we also
(E) Confocal micrograph of Actinin-BirA* iPSC-CMs decorated with antibodies to actinin (red), streptavidin-AF488 (green), and DAPI DNA co-stain (blue) (scale
bar, 10 mm).
(F) Overview of BioID experimental methods.
(G) iPSC-CM lysates were probed with streptavidin-horseradish peroxidase (HRP) to examine Actinin-BirA*-biotinylated proteins.
(H) Heatmap and hierarchical clustering of log2-transformed intensity values for the 324 Actinin-BirA* hits (L2FCR 1 and FDR < 0.05 relative to control non-BirA*)
from combined TMT experiments.
(I) Venn diagram of ACTN2 BioID protein dataset (red circle) and published ACTN interactors obtained from STRING where ACTN was bait (gray circle).
(J) 324 proteins from ACTN2 BioID were analyzed by GO and key enrichment terms are listed.
(K) ACTN2 BioID proteins in RNA-binding GO term were uploaded to STRING for subnetwork analysis. The resulting network was imported into Cytoscape
(v. 3.7.2) and CLUSTER and BINGO features were utilized for clustering and GO term identification. Hits that were additionally studied are circled in black.
Data are nR 3 (C and D); mean ± SEM; significance assessed by Student’s t test (C and D) or two-way ANOVA followed by a two-stage linear step-up procedure
of Benjamini, Krieger, and Yekutieli to correct for multiple comparisons (H) and defined by p > 0.05 (ns) (C and D). See also Figure S1 and Video S1.




identified enrichment of other late-assembling proteins,
including TCAP and CSRP3 (White et al., 2014). The most en-
riched sarcomere assembly partner was SYNPO2L, a known
binding partner of actinin that is critical to heart and skeletal
muscle development (Beqqali et al., 2010). Taken together,
we identified actinin interactomes through Z-body and Z-disk
stages, including stage-specific RNA-binding proteins and
stage-enriched myosins and late-assembling proteins.
We next focused our analysis on RNA-binding proteins in
proximity to actinin, as these factors were identified in Z-disks
(Figure S1I) and have been less studied relative to actin cytoskel-





































































































































































































































































Figure 2. Identification of transcripts bound to RNA-binding proteins in actinin neighborhoods
(A) Overview ofmodified RIP-seq protocol to study RNA transcripts bound to RNA-binding proteins in actinin neighborhoods by streptavidin affinity purification of
RNA-binding proteins followed by RNA isolation and sequencing.
(B) PCA plot shows clustering of Actinin-BirA* RIP-seq samples relative to non-BirA* controls (n = 4).
(C) Volcano plot of RIP-seq data shaded red for 945 enriched transcripts (FDR < 0.05, L2FC R 0.5) or blue for 1,113 depleted transcripts (FDR < 0.05, L2FC %
0.5). Differentially enriched transcripts were analyzed by GO and enrichment terms are listed for enriched and depleted transcripts.
(D) ETC gene components spanning respiratory chain complex I-V proteins are enriched on average. Each circle represents a single ETC gene; black circle for
statistically significant transcript.
(E) Glycolysis gene components are not enriched on average. Each circle represents a single glycolysis gene.
(F) Thin and thick filament sarcomere are depleted on average. Each circle represents a single sarcomere gene.
(G) qPCR validation of candidate RIP-seq hits (n = 4).
(H) Representative confocal micrograph of iPSC-CMs decorated with antibodies to actinin (red), DAPI DNA co-stain (blue), and RNA FISH probes against
NDUFA1 (green) (scale bars: main image, 10 mm; inset, 5 mm).
(I) Representative confocal micrograph of iPSC-CMs decoratedwith antibodies to actinin (red), DAPI DNA co-stain (blue), and RNA FISH probes againstNDUFA8
(cyan) (scale bars: main image, 10 mm; inset, 5 mm).
(J) Quantification of RNA proximity to actinin protein. Statistics are relative to TTN. Data are derived from n = 10 cells.
Data are mean ± SEM; significance assessed by Benjamini Hochberg method (C) or ANOVA using Holm-Sidak correction for multiple comparisons (G and J) and
defined by p < 0.05 (*), p % 0.01 (**), p % 0.001 (***), p % 0.0001 (****) unless otherwise stated. See also Figure S2.




identified 99 proteins with general RNA-binding functions (Fig-
ure 1J), including those with subfunctions in ribosomal assem-
bly, transcription/translation, and RNA metabolism (Figure 1K).
Proteins involved in RNA metabolism include regulators of
RNA splicing, localization, stability, and translation (Van Nos-
trand et al., 2020). Except for SRSF1, which has been implicated
in cardiac electrophysiology, and PCBP2, which has been impli-
cated in hypertrophic signaling (Xu et al., 2005; Zhang et al.,
2015), the cardiac functions of many of these proteins are un-
known. Overall, our BioID study reveals a compendium of actinin
interaction partners within cardiomyocytes through sarcomere
assembly including a network of RNA-binding proteins with
diverse functions including RNA localization.
Identification of transcripts bound to RNA-binding
proteins in actinin neighborhoods
To reveal functional insights into actinin interactions with RNA-
binding proteins, we next sought to identify gene transcripts
bound to RNA-binding proteins in actinin neighborhoods. To do
this, we performed RNA immunoprecipitation followed by
sequencing (RIP-seq) (Tenenbaum et al., 2000) using streptavidin
affinity purification to pull down RNA-binding proteins that were
biotinylated because they were localized within 10 nm of Acti-
nin-BirA* (Figure 2A). Principal-component analysis (PCA) demon-
strated clustering of Actinin-BirA* transcripts compared to non-
BirA* controls (Figure 2B), and differential expression analysis
identified 945 transcripts bound to biotinylated RNA-binding pro-
teins (Table S2). GO analysis (Figure 2C) revealed enrichment of
ETC and ribosome transcripts (Figures 2D and S2A). In contrast,
we observed no enrichment for glycolysis transcripts (Figures
2E and S2B). 1,113 transcripts were depleted and clustered into
GO terms for chromatin and nuclear functions (Figure 2C). Cyto-
skeletal transcripts, including those encoding thin and thick fila-
ment sarcomere proteins, were also depleted (Figures 2F and
S2C). In summary, RIP-seq demonstrated that RNA-binding pro-
teins that were in actinin neighborhoods bind specific ETC and
ribosome transcripts, which provided preliminary evidence that
these interactions could be important for metabolic and transla-
tional functions, respectively.
Following qPCR validation of ETC transcript enrichment iden-
tified by RIP-seq (Figure 2G), we performed RNA fluorescence in
situ hybridization (RNA FISH) with Imaris distance quantification
(Figure S2D) to validate actinin neighborhood transcripts. We
first conducted a control RNA FISH experiment excluding only
the RNA probe to verify specificity of the RNA FISH signals (Fig-
ure S2E). Next, we found that RNA puncta encoding ETC
componentNDUFA1weremore likely to be localized near actinin
protein relative to the sarcomere thick filament transcript TTN
that served as a control because it was not RIP-seq enriched
(Figures 2H, 2J, and S2J). Over 50%ofNDUFA1 puncta overlap-
ped actinin, but almost no puncta were greater than 1 mm from
actinin. We confirmed specificity of the NDUFA1 probe by using
small hairpin RNA (shRNA) to knock down NDUFA1 in iPSC-
CMs, which demonstrated a reduction in NDUFA1 mRNA levels
and RNA FISH puncta (Figures S2F–S2H). Similar to NDUFA1,
we also confirmed actinin proximity forNDUFA8 transcripts (Fig-
ures 2I and 2J). We next assessed colocalization between
NDUFA1 and NDUFA8 transcripts, which could reflect potential
ETC transcript storage or processing mechanisms. While both
NDUFA1 and NDUFA8 transcripts localized in actinin neighbor-
hoods, they did not overlap each other (Figure S2I). Finally, we
confirmed that two transcripts that were depleted by RIP-seq
analysis, H1 family linker histone HIST1H1E and sarcoplasmic
reticulum protein HRC, were not associated with actinin neigh-
borhoods (Figures 2J, S2K, and S2L). Together, these data vali-
date our RIP-seq study and confirm that specific ETC transcripts
are localized in actinin neighborhoods.
Fine mapping actinin interactions with the RNA-binding
protein IGF2BP2
Informed by RIP-seq results that demonstrated ETC transcripts
within actinin neighborhoods, we searched for RNA-binding pro-
teins that could regulate this localization. We focused on candi-
date RNA-binding proteinswith previously knownmetabolic func-
tions, including IGF2BP2 (Saxena et al., 2007), PCBP1 (Ryu et al.,
2017), PCBP2 (Frey et al., 2014), and SERBP1 (Muto et al., 2018;
Figure 1K). After confirming actinin proximity for the four hits using
streptavidin affinity purification followed by immunoblotting in
iPSC-CM lysates (Figure 3A), we confirmed that actinin interacts
directly or within a complex with three of the hits, including
IGF2BP2, PCBP1, and PCBP2, using co-immunoprecipitation of
Actinin-BirA* itself using an HA epitope antibody followed by hit-
specific antibodies (Figure 3B). Only SERBP1 did not co-immuno-
precipitate with actinin, which suggested amore complex interac-
tion mechanism. We also studied the type of interaction between
actinin and IGF2BP2, PCBP1, PCPB2, and SERBP1 using lucif-
erase-based mammalian 2-hybrid (M2H) assays in HEK293T
cells. We began by constructing expression vectors encoding
full-length or previously identified structural domains of actinin
and the four RNA-binding proteins. M2H using IGF2BP2 as
‘‘prey’’ and full-length actinin as ‘‘bait’’ resulted in luciferase acti-
vation, but not for PCBP1, PCBP2 or SERBP1 (Figure 3C). In addi-
tion, weobserved colocalization of IGF2BP2with actinin by immu-
nofluorescence at a subset of iPSC-CM Z-disks (Figure 3D).
Taken together, these studies demonstrated four candidate
RNA-binding proteins in actinin neighborhoods, including
IGF2BP2, that directly interact with actinin and localize to Z-disks.
UsingM2H,we then finemapped the IGF2BP2-actinin interac-
tion to IGF2BP2’s K homology (KH) domain, but not its RNA
recognitionmotif (RRM) (Figure 3E), and IGF2BP2’s actinin-bind-
ing site to actinin’s rod domain, but not its AB or CaM domains
(Figure 3F). As actinin’s rod domain consists of four SRs (Fig-
ure 3F; Ribeiro et al., 2014), we additionally studied single SR
deletion constructs, which confirmed that both SR2 and SR3
were required for actinin-IGF2BP2 interactions, but not SR1 or
SR4 (Figure 3G). To fine map the interaction between SR2 and
SR3 with IGF2BP2, we utilized alanine scanning (Weiss et al.,
2000), as we observed that smaller deletions within either SR2
or SR3 disturbed actinin dimerization as well as IGF2BP2 inter-
actions, which is consistent with previous actinin dimerization
studies (Djinovic-Carugo et al., 1999). To establish a method to
disrupt actinin-IGF2BP2 interactions, but not actinin dimeriza-
tion, we took advantage of previous insights from structural
studies of SR2 and SR3 domains (Ylänne et al., 2001). These do-
mains contribute an acidic surface to actinin, which has been
previously proposed as a protein interaction hub (Figures 3H










Figure 3. Fine mapping actinin interactions with the RNA-binding protein IGF2BP2
(A) Representative immunoblot probed with antibodies to IGF2BP2, PCPB1, PCPB2, and SERBP1 in streptavidin affinity-purified iPSC-CM lysates. Double band
represents two IGF2BP2 splice products.
(B) Representative immunoblot probed with antibodies to IGF2BP2, PCPB1, PCPB2, and SERBP1 in anti-HA immunoprecipitated iPSC-CM lysates.
(C) M2H (conducted in HEK293T cells) results demonstrating that IGF2BP2 interacts with full-length actinin, but not PCBP1, PCPB2, or SERBP1.
(D) Representative confocal micrograph demonstrating partial colocalization of actinin (anti-actinin; red) with IGF2BP2 (anti-IGF2BP2; green) with DAPI DNA
(blue) co-stain in iPSC-CMs (scale bars: main image, 10 mm; inset, 5 mm).
(E) M2H study conducted to finemap the direct interaction between actinin and IGF2BP2. IGF2BP2was divided into RRM (residues 1–160) and KH (residues 161–
600) domains to fine map the interaction.
(F) M2H results to map the direct interaction between the KH domain of IGF2BP2 and Actinin. Actinin was divided into AB (residues 1–275), rod (residues 276–
750), and CaM domains (residues 751–895).
(G) M2H results to map IGF2BP2’s interaction within actinin rod domain through deletions of each spectrin repeat (SR).
(legend continued on next page)




and 3I; Ylänne et al., 2001). We designed a series of single
alanine substitutionmutations to disrupt the charge of acidic res-
idues within SR2, after excluding residues that were predicted to
contribute intrahelical interactions that could disrupt actinin
dimerization or other actinin functions (Ylänne et al., 2001).
M2H results of single alanine substitutions within this subset of
acidic SR2 residues identified only glutamine 445 (E445) as
necessary for IGF2BP2 interactions (Figures 3I and 3J) but did
not disrupt actinin dimerization (Figure 3K). As E445A provided
a model to specifically disrupt actinin-IGF2BP interactions, we
did not study SR3 substitutions.
To validate M2H results for E445A, we next produced recombi-
nant His-tagged WT and E445A actinin in E. coli that were inde-
pendently immobilized on agarose beads as bait, followed by
elution of IGF2BP2 prey from iPSC-CM lysates. Consistent with
M2H results, E445A actinin partially disrupted IGF2BP2 interac-
tions relative to WT actinin (Figure S3A). Taken together, these
interaction studies (summarized in Figure S3B) implicate actinin
as a proximity interaction hub for at least four RNA-binding pro-
teins, including IGF2BP2, that directly bind actinin at SR2 and
SR3 domains, which can be disrupted by the E445A mutation in
actinin.
Actinin-IGF2BP2 interactions regulate ETC transcript
localization to actinin neighborhoods and metabolic
adaptation to hypercontractility in an HCM model
As IGF2BP2 binds ETC transcripts in other cell lines (Janiszew-
ska et al., 2012), we testedwhether IGF2BP2 could be necessary
for ETC transcript localization to actinin neighborhoods in iPSC-
CMs. We knocked down IGF2BP2 levels using an shRNA (Fig-
ure 4A), and performed RIP-qPCR focused on RIP-seq enriched
ETC transcripts NDUFA1, NDUFA8, NDUFA11, and COX6B1.
IGF2BP2 knockdown decreased streptavidin affinity-purified
ETC transcripts (Figure 4B), but not total cellular ETC transcript
levels (Figure 4C), demonstrating that IGF2BP2 is necessary
for ETC transcript localization to actinin neighborhoods but not
overall transcript stability. To confirm this result, we also sequen-
tially precipitated transcripts by IGF2BP2 antibody to first collect
all IGF2BP2-bound transcripts, followed by streptavidin affinity
purification to study the subset of IGF2BP2-bound transcripts
that have been biotinylated secondary to actinin proximity,
which confirmed ETC transcript enrichment at IGF2BP2 within
actinin neighborhoods (Figure S4A). As additional confirmation,
we utilized RNA FISH to quantify NDUFA1 puncta relative to ac-
tinin after IGF2BP2 knockdown. IGF2BP2 knockdown resulted in
greater distance between NDUFA1 puncta and actinin protein
(Figures S4B and S4C). In summary, IGF2BP2 regulates the
localization of ETC transcripts to actinin neighborhoods.
We next interrogated the specific function of actinin-IGF2BP2
interactions in iPSC-CMs. To do this, we generated lentivirus en-
coding E445A orWT actinin, which has been previously utilized to
study actinin functions in sarcomere assembly (Chopra et al.,
2018; Toepfer et al., 2019). Amultiplicity of infection (MOI) of 2 pro-
vided robust expression levels that replaced >80% of the endog-
enous protein (Figure S4D) and localized to Z-disks (Figure S4E).
Wefirst conductedRIP-qPCR to assesswhether E445A disrupted
ETC transcript localization to actinin neighborhoods. As expected
by diminished actinin-IGF2BP2 interactions, E445A disrupted ac-
tinin neighborhood localization of NDUFA1, NDUFA8, NDUFA11,
and COX6B1 (Figure 4D), though not to the extent of IGF2BP2
knockdown (Figure 4B), given that E445A does not completely
abolish all IGF2BP2 interactions. Similarly, E445A resulted in
greater distance between NDUFA1 puncta and actinin protein
(Figure S4F) but to a lesser extent than IGF2BP2 knockdown (Fig-
ure S4C). Next, we studied the functional consequences of E445A
on sarcomere structure and function.We found no difference in Z-
disk length (Figure S4G), a previously utilized assay of sarcomere
structure (Pettinato et al., 2020), and no difference in sarcomere
contractile function using CMT assays (Figure S4H). To test
whether E445A impacts oxidative phosphorylation as suggested
by diminished ETC transcript localization to actinin neighbor-
hoods, we quantified oxygen consumption rate (OCR) using a
Seahorse analyzer (Figure 4E). OCR was also not different (Fig-
ure 4F). In summary, we could not identify baseline sarcomere
or oxidative metabolic deficits induced by E445A actinin.
To test whether actinin-IGF2BP2 interactions could function in
stress responses, we studied pathological sarcomere activation
using a well-established HCM model resulting from a calcium-
sensitizing mutation in cardiac troponin T (cTnT-R92Q) (Ferrantini
et al., 2017; Javadpour et al., 2003; Pettinato et al., 2020). First, we
co-transduced cTnT-R92Q or cTnT-WT along with E445A or WT
actinin and measured OCR. We expected to observe increased
OCR in response to sarcomere activation, because this process
consumes substantial ATP (Lymn and Taylor, 1971), and cardio-
myocytes predominantly utilize oxidativemetabolism for ATP pro-
duction (Stanley et al., 2005). cTnT-R92Q increased basal and
maximum OCR responses relative to cTnT-WT (Figures 4E and
4F). However, in the presenceof E445A actinin, theOCR response
was disrupted relative toWT actinin (Figures 4E and 4F). To deter-
mine functional consequences of diminished OCR responsive-
ness to pathological sarcomere activation, we took advantage
of previous knowledge that cells with disrupted OCR are less
viable when glucose is replaced by galactose to force oxidative
metabolism (Aguer et al., 2011; Robinson et al., 1992). To do
this, we substituted glucose for galactose and measured iPSC-
CM cytotoxicity by lactate dehydrogenase (LDH) release assays.
When glucose was freely available, LDH release was negligible in
conditionedmedia during the 5-day culture across all models (Fig-
ure S4I). However, in glucose-free media supplemented with
galactose to force oxidative metabolism, we found that cTnT-
R92Q induced earlier and greater LDH release when co-ex-
pressed with E445A actinin compared to WT actinin (Figure 4G).
(H) Ribbon structure PyMOL of actinin’s SR2 and SR3 domains (SR2 highlighted in red).
(I) Visualization of electrostatic potential of SR2 and SR3 domains. Actinin residue E445 circled in diagram and shaded yellow.
(J) M2H alanine scanning mutagenesis results within actinin SR2 domain with IGF2BP2 demonstrates partial disruption by E445A.
(K) M2H results demonstrating preservation of wild-type (WT) actinin interaction with E445A actinin.
All data are n = 3 and mean ± SEM; significance assessed by ANOVA using Holm-Sidak correction for multiple comparisons (C, E, F, G, J, and K) and defined by
p > 0.05 (ns), p % 0.0001 (****). See also Figure S3.




Taken together, these results demonstrate that actinin-IGF2BP2
interactions function in metabolic responses to sarcomere activa-
tion that are critical for cell survival in an HCM model.
DISCUSSION
The principal finding of this study is that actinin directly interacts
with the RNA-binding protein IGF2BP2 in human cardiomyocytes.
Disruption of this interaction impairs ETC transcript localization to
actinin neighborhoods, oxidative metabolism, and cell survival in
an HCM model associated with pathological sarcomere activa-
tion. Our study also provides a compendium of over 300 actinin
proximity partners involved in numerous cellular functions,
including cytoskeletal dynamics and cellular adhesion, as well
as molecular insights into Z-disk assembly, including Z-body-
and Z-disk-specific factors relevant to heart failure.
Our study prioritized establishing actinin functions in RNA
biology that was inspired by our identification of a large network
of RNA-binding proteins within actinin neighborhoods, including
those with previous functions in RNA localization. In zebrafish,
71% of transcripts are localized in spatially distinct patterns (Lé-
cuyer et al., 2007), which provides spatial and temporal regula-
tion of gene expression such that local stimuli can regulate trans-
lation on-site (Martin and Ephrussi, 2009). While the sarcomere
has been implicated in the regulation of RNA localization and
functions (Lewis et al., 2018; Rudolph et al., 2019), we find that
actinin serves as a PPI hub for several RNA-binding proteins
and translational machinery, which we exploited to uncover a
spatial relationship between ETC transcripts and actinin expres-
sion. Through follow-up studies, this PPI hub may explain mech-
anisms for the previous observation that intermyofibrillar mito-
chondria both reside adjacent to the Z-disk (Boncompagni
et al., 2009) and have higher rates of oxidative phosphorylation
(Ferreira et al., 2010).We observe that ETC transcript localization
to actinin neighborhoods is dependent on IGF2BP2, an














































































































































































































Figure 4. Actinin-IGF2BP2 interactions regulate ETC transcript localization to actinin neighborhoods and metabolic adaptation to hyper-
contractility in an HCM model
(A) Representative immunoblot of lysates from iPSC-CMs treated with shRNA targeting IGF2BP2 or scramble control probed with antibodies to IGF2BP2 and
GAPDH.
(B) Streptavidin affinity purification of transcripts bound to RNA-binding proteins in actinin neighborhoods after IGF2BP2 knockdown, followed by qPCR of ETC
transcripts NDUFA1, NDUFA8, NDUFA11, and COX6B1.
(C) qPCR analysis of global transcript levels of NDUFA1, NDUFA8, NDUFA11, and COX6B1 after IGF2BP2 knockdown.
(D) Streptavidin affinity purification of transcripts bound to actinin-proximal RNA-binding proteins with overexpressing lenti-Actinin-WT or lenti-Actinin-E445A,
followed by qPCR of ETC transcripts NDUFA1, NDUFA8, NDUFA11, and COX6B1.
(E) Oxygen consumption rates after co-overexpression of either lenti-Actinin-WT or lenti-Actinin-E445A with lenti-cTnT-WT or lenti-cTnT-R92Q in iPSC-CMs.
(F) OCR parameter quantifications comparing lenti-Actinin-WT and lenti-Actinin-E445A with either lenti-cTnT-WT or lenti-cTnT-R92Q.
(G) LDH activity in conditioned media collected from iPSC-CMs expressing either lenti-Actinin-WT or lenti-Actinin-E445A with lenti-cTnT-WT or lenti-cTnT-R92Q
in glucose-free media supplemented with galactose for 5 days.
Data are nR 3; mean ± SEM; significance assessed by Student’s t test (A–D) or by ANOVA using Holm-Sidak correction for multiple comparisons (F and G) and
defined by p < 0.05 (*), p % 0.01 (**), p % 0.001 (***), p % 0.0001 (****). See also Figure S4.




genome-wide association studies (Saxena et al., 2007). In our
study, partial disruption of actinin-IGF2BP2 interactions by
substituting glutamic acid to alanine at residue 445 resulted in
both diminished oxygen consumption rates and cell survival
following pathological sarcomere activation induced by an
HCM mutation. While requiring further study, this interaction
may also be relevant to the pathogenesis of diabetic cardiomy-
opathy (Jia et al., 2018), as IGF2BP2 knockout mice have been
shown to exhibit impaired fatty acid oxidation in skeletal muscle,
where actinin is also highly expressed (Regué et al., 2019), and
may provide a lever to locally tune energy supply with energy
consumption at the sarcomere.
Our study has important limitations, including the use of hu-
man iPSC-CMs. These cells empowered the opportunity to
study sarcomere assembly in a human cellular context but do
not achieve the maturity of adult cardiomyocytes. In the future,
engineering and investigating mouse models with Actinin-
BirA*, such as has been performed with TTN (Rudolph et al.,
2020), could further refine and clarify Z-disk interactions in the
healthy heart and diseases such as heart failure. Our study could
also be extended to employ more dynamic approaches such as
with the recently described TurboID enzyme (Branon et al.,
2018), which exhibits improved biotinylation kinetics and label-
ing efficiencies compared to BirA*. Our RIP-seq approach is
also limited by the inability to directly label actinin-proximal tran-
scripts, which could be enabled by the recently developed
method of APEX-RIP (Kaewsapsak et al., 2017). Finally, our
determination of RNA transcript localization was performed us-
ing confocal microscopy, which is resolution limited relative to
super-resolution microscopy methods.
In summary, we provide a catalog of actinin neighborhood
partners, including those regulated by sarcomere assembly
and molecules not well studied in sarcomere biology, including
RNA-binding factors that regulate RNA localization. We identify
how interactions between actinin and IGF2BP2 contribute to
cardiomyocyte metabolic adaptations to stress, which we sug-
gest could be a mode of localized metabolic regulation in prox-
imity to the energy-consuming sarcomere. Further exploration
and refinement of these interactions could reveal therapeutic tar-
gets and pathophysiology for diseases of the cardiomyocyte that
cause heart failure, diabetes, and monogenic disorders associ-
ated with actinin mutations.
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REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Alpha-actinin Cell Signaling Cat. #6487; RRID:AB_11179206
GAPDH Cell Signaling Cat. #2118; RRID:AB_561053
HA-Tag Cell signaling Cat. #14793; RRID:AB_2572291
IGF2BP2 MBL Cat. #RN008P; RRID:AB_1570641
PCBP1 Abcam Cat. #74793; RRID:AB_1281060
PCBP2 MBL Cat. #RN250P; RRID:AB_1953052
SERBP1 Abcam Cat. #55993; RRID:AB_882495
TCAP BD Cat. #612328; RRID:AB_399643
FLAG-Tag Cell Signaling Cat. #2368; RRID:AB_2217020
MYOM DSHB Cat. #760349; RRID:AB_760349
Streptavidin-HRP Cell Signaling Cat. #3999S; RRID:AB_10830897
Goat anti-rabbit IgG HRP Cell Signaling Cat. #7074; RRID:AB_2099233
Goat anti-mouse IgG HRP Cell Signaling Cat. #7076; RRID:AB_330924
Alpha-actinin Sigma Cat. #A7811; RRID:AB_476766
IGF2BP2 Bethyl Cat. #A303-316A; RRID:AB_10951966
Streptavidin-488 Invitrogen Cat. #S11223; RRID:AB_2315383
Goat anti-mouse 594 Invitrogen Cat. #A11005; RRID:AB_141372
Goat anti-rabbit 488 Invitrogen Cat. #A11008; RRID:AB_143165
NDUFA1 (RNA probe) Invitrogen Cat. #VA6-3172657
NDUFA8 (RNA probe) Invitrogen Cat. #VA1-3003564
TTN (RNA probe) Invitrogen Cat. #VA6-3173894
HIST1H1E (RNA probe) Invitrogen Cat. #VA6-3172001
HRC (RNA probe) Invitrogen Cat. #VA6-3172126
IgG MBL Cat. #PM035; RRID:AB_10805234
Critical commercial assays
NextSeq 500/550 v2 Illumina Cat. #FC4042005
HiFi DNA Assembly New England BioLabs Cat. #E2621
T4 DNA ligase New England BioLabs Cat. #M0202S
Seahorse XF Cell Mito Stress Agilent Cat. #103015-100
Qubit dsDNA kit Invitrogen Cat. #Q32854
Fast SYBR Green Master Mix Applied Biosystems Cat. #4385612
HA-tag IP/Co-IP Application set Thermo Scientific Cat. #26180Y
Superscript III First-Strand synthesis Invitrogen Cat. #18080-400
ViewRNA in situ hybridization kit Invitrogen Cat. #19887
CheckMate Mammalian Two-Hybrid kit Promega Cat. #E2440




LDH toxicity assay kit ThermoFisher Cat. #C20300
Experimental models: cell lines and animals
PGP1 human iPSCs Coriell Cat. #GM23338
HEK293T ATCC Cat. #CRL3216
(Continued on next page)





REAGENT or RESOURCE SOURCE IDENTIFIER
Oligonucleotides
HR220PA SBI Cat. #HR220PA-1
psPAX2 Gift from Didier Trono Addgene Cat. #12260
pCMV-VSV-G Stewart et al., 2003 Addgene Cat. #8454
pCas9-GFP Ding et al., 2013 Addgene Cat. #44719
pLenti CMV GFP Puro Campeau et al., 2009 Addgene Cat. #17448
pLKO.1 Sarbassov et al., 2005 Addgene Cat. #1864
pNIC28-Bsa4 Savitsky et al., 2010 Addgene Cat. #26103
Software and algorithms
STAR (v.2.5.4a) GitHub https://github.com/alexdobin/STAR




STRING (v. 11.0) STRING https://string-db.org/




Cytoscape (v. 3.7.2) Cytoscape https://cytoscape.org/
PyMOL (v. 2.4.0) PyMOL https://pymol.org/2/
Imaris visualization and analysis software BitPlane Institutional license
https://imaris.oxinst.com/
Chemicals, peptides, and recombinant proteins
IWP4 Tocris Cat. #5214
CHIR99021 Tocris Cat. #4423
Y-276932 Tocris Cat. #1254
Fibronectin (human) Corning Cat. #33016015
Matrigel GFR Corning Cat. #354230
Biotin ThermoFisher Cat. #29129
ROCK inhibitor Y-27632 Tocris Cat. #1254
CHIR99021 Cayman Cat. #13122
IMP2 peptide Genescript Custom order
Other
Accutase BD Biosciences Cat. #561527
RPMI 1640 ThermoFisher Cat. #11875093
DMEM (glucose-free) GIBCO Cat. #11966025
Opti-MEM GIBCO Cat. #31985062
Polyethylenimine (PEI) Polysciences Cat. #239662
PEG-6000 Millipore Sigma Cat. #528877
Trypsin-EDTA GIBCO Cat. #25200056
Hygromycin Invitrogen Cat. #10687010
TRIzol Invitrogen Cat. #15596018
Dynabeads MyOne Streptavidin C1 beads Invitrogen Cat. #65001
Dynabeads Proteins G Invitrogen Cat. #10003D
Puromycin GIBCO Cat. #A1113803
B27 supplement GIBCO Cat. #17504044
B27 supplement (-insulin) GIBCO Cat. #A1895601
Penicillin/Streptomycin GIBCO Cat. #15140122
(Continued on next page)






Requests for information and resources should be directed to the Lead Contact, Dr. J. Travis Hinson (travis.hinson@jax.org).
Materials availability
Materials generated in this study are available from the Lead Contact upon reasonable request.
Data and code availability
d Genome sequencing datasets for RIP-sequencing are deposited at GEO under accession numbers: GSE144806. Quantitative
proteomics data deposited to the ProteomeXchange Consortium identifier PXD018040.
d No unique code was generated for the analysis.
d Any additional information required to reanalyze the data reported in this paper is available from the Lead Contact upon
request.
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
GlutaMAX GIBCO Cat. #35050061
Sodium lactate Sigma Cat. #71718
mTeSR1 STEMCELL Technologies Cat. #85850
DAPI Invitrogen Cat. #D1306
Fetal bovine serum (heat-inactivated) Gemini Cat. #100-106
PBS GIBCO Cat. #10010049
PDMS Corning Cat. #4019862
Florescent microbeads ThermoFisher Cat. #F8820
Paraformaldehyde EMS Cat. #50-980-487
10 mM galactose Sigma Cat. #59234
KOD Hot Start Master Mix MilliporeSigma Cat. #71842-4






ProLong Gold Mountant Invitrogen Cat. #P36965
4-20% Mini-PROTEAN TGX gels Bio-Rad Cat. #4561095
RTA PVDF Transfer kit Bio-Rad Cat. #1704272
BSA, Fraction V Fisher Cat. #BP1605
Pyruvate GIBCO Cat. #11360070
Tris-Glycine SDS 10X Fisher Cat. #BP13414
BL21 E.coli cells New England BioLabs Cat. #C2527I
IPTG ThermoFisher Cat. #R1171
DH5a E.coli cells New England BioLabs Cat. #C2987
Stbl3 E.coli cells Invitrogen Cat. #C737303
NEB stable E.coli cells New England BioLabs Cat. #C3040
4mm cuvettes Bio-Rad Cat. #1652088
RIPA buffer Cell Signaling Cat. #9806
Protease inhibitor cocktail Roche Cat. #11836170001
Phosphatase inhibitor Pierce Cat. #A32957
BCA kit ThermoFisher Cat. #23225
Protein sample buffer ThermoFisher Cat. #39000
Deposited data
Proteomics data ProteomeXchange PXD018040
RIP-seq data GEO GSE144806




EXPERIMENTAL MODEL AND SUBJECT DETAILS
PGP1 iPSCs (Coriell #GM23338) were used for all studies, which have been extensively characterized including whole genome
sequencing and karyotyping as part of the ENCODE project (ENCBS368AAA). iPSCs were maintained onMatrigel-coated tissue cul-
ture plates (Corning 354230) in mTeSR1 (STEMCELL Technologies 85875). iPSCs were passaged at 80%–90% confluency utilizing
Accutase (BD 561527) and 10 mM ROCK inhibitor Y-27632 (Tocris 1254). iPSC-CMs were directly differentiated by sequential mod-
ulation of Wnt/b-catenin signaling, as previously described (Cohn et al., 2019; Lian et al., 2013). On Day 13 of differentiation, iPSC-
CMs were purified by metabolic enrichment using glucose-free DMEM (GIBCO 11966025) supplemented with 4 mM lactate (Sigma
71718) for 24-48 hours (Tohyama et al., 2013). Following selection, iPSC-CMswere trypsinized (GIBCO 25200056) and re-plated onto
fibronectin-coated tissue culture plates (GIBCO 33016015). iPSC-CMs were maintained in RPMI-B27. For proximity-labeling exper-
iments, Actinin-BirA* and control non-BirA* iPSC-CMsweremaintained in DMEM (GIBCO 11965092) supplemented with homemade
biotin-free B27 following metabolic enrichment (Gafni et al., 2013; Irie et al., 2015). For BioID studies, Actinin-BirA* and control non-
BirA* iPSC-CMs were treated with 50 mM biotin for 24 hours followed by a 2-hour washout phase in biotin-free media before collec-
tion. All iPSC-CM analyses were performed on Day 25-30 unless otherwise noted.
METHOD DETAILS
Plasmid Cloning
The homologous recombination (HR) targeting vector (SystemBiosciences HR220PA-1) wasmodified prior to being used in genome-
editing experiments. A gene fragment for BirA* (R118G)-HA tag was designed, obtained (IDT) and cloned into the parent vector via
Gibson assembly (NEB E2621). ACTN2800bp 50 and 30 HR arm gene fragments (IDT) were then cloned into the appropriate cloning
sites (sequences in Table S3). All HR vector propagation steps were performed in DH5a E.coli (NEB C2987). For hairpin (shRNA) ex-
periments, the pLKO.1 puro lentiviral plasmids containing either shScramble (Addgene 1864), shIGF2BP2 or a1 (sequence in Table
S3) were assembled using T4 DNA ligase (NEB M0202S) and propagated in NEB Stable E.coli (NEB C3040). For overexpression ex-
periments, PCR amplified products of actinin (primer sequences in Table S3) were cloned into a modified pLenti CMV backbone
(Addgene 17448) using HIFI DNA Assembly Master Mix (NEB 26261S) and propagated in NEB Stable E.coli (NEB C3040) (Campeau
et al., 2009). For cTnT expression, vectors were obtained as previously described (Pettinato et al., 2020).
CRISPR studies
Genome editing was performed utilizing a CRISPR/Cas9 protocol adapted from previous studies (Cohn et al., 2019; Hinson et al.,
2015). 8x106 iPSCs were electroporated with 20 mg pCas9-GFP (Addgene 44719), 20 mg of the appropriate hU6-driven sgRNA (de-
signed using https://zlab.bio/guide-design-resources), and 20 mg of the HR targeting vector to generate ACTN2-BirA* knock-in
iPSCs (Ding et al., 2013). Electroporated cells were transferred to a Matrigel-coated 100 mm dish containing mTeSR1 and 10 mM
Y-27632. The following day, selection was started with 50 mg/mL Hygromycin B (Invitrogen 10687010) to isolate single iPSC clones,
which were then manually picked, expanded, and screened via Sanger sequencing. Isogenic knockout of TNNT2 was performed
similarly, but in the absence of an HR vector and with GFP-based FACS enrichment in place of antibiotic selection.
Streptavidin immunoprecipitation
After biotin washout, Actinin-BirA* and control non-BirA* iPSC-CMs were rinsed three times with room temperature PBS. Cells were
lysed with lysis buffer (50 mM Tris-Cl pH7.4, 500 mM NaCl, 0.2% SDS, 1x protease inhibitor, 1mM DTT, ddH2O). Lysates were son-
icated (Branson 250) two times on ice with 2 minutes between each cycle (30 pulses, 30% duty cycle, output level3). Samples were
centrifuged to pellet cell debris and cleared lysate were added to magnetic Dynabeads MyOne Streptavidin C1 beads (Invitrogen
65001), which were prewashed with PBS and lysis buffer. Immunoprecipitation was performed on a rotator overnight at 4C. The
following day, the beads were resuspended in wash buffer 1 (2% SDS, ddH2O), rotated for 8 minutes at room temperature, and
then re-collected using a magnetic separation stand. The same steps were then repeated with wash buffer 2 (0.1% deoxycholic
acid, 1% Triton X-100, 1mM EDTA, 500 mM NaCl, 50 mM HEPES pH7.5, ddH2O) and wash buffer 3 (0.5% deoxycholic acid,
0.5% NP-40, 1 mM EDTA, 250 mM LiCl, 10 mM Tris-Cl pH7.4, ddH2O). Finally, the washed beads were resuspended in PBS,
snap frozen, and sent for quantitative proteomics.
HA immunoprecipitation
Actinin-BirA* and control non-BirA* iPSC-CMswere collected at Day 25 andHA-tag IPwas conducted using reagents supplied in HA-
tag IP/Co-IP Application set (Thermo Scientific 26180Y). The subsequent protein immunoblots were conducted as outlined in the
immunoblot section.
RNA Immunoprecipitation (RIP)
After biotin washout, Actinin-BirA* and control non-BirA* iPSC-CMs were rinsed three times with room temperature PBS. Cells were
lysedwith ice-cold RIP buffer (150mMKCl, 25mMTris-Cl pH7.4, 5mMEDTA, 0.5mMDTT, 0.5%NP40, 1x protease inhibitor, 100U/
ml RNase inhibitor, RNase-free water). Cell debris was pelleted and cleared lysate was added to magnetic Dynabeads MyOne




Streptavidin C1 beads (Invitrogen 65001), which were prewashed with PBS and RIP buffer. Samples and beads were incubated on a
rotator overnight at 4C. The following day, the beads were washed three times with ice-cold RIP buffer – all steps were performed in
a 4C room. Samples were then incubated with Proteinase K at 55C for 30 minutes. Beads were resuspended in TRIzol (Invitrogen
15596018), RNA extraction was performed immediately followed by RNA-sequencing.
Tandem Immunoprecipitation
After biotin washout, Actinin-BirA* and control non-BirA* iPSC-CMs were rinsed three times with room temperature PBS and then
lysed in RIP buffer. Cleared lysates were incubated with Dynabeads Protein G (Invitrogen 10003D) pre-bound to either IgG antibody
(MBL PM035) or IGF2BP2 antibody (MBL RN008P). Samples and beads were incubated on a rotator overnight at 4C. The following
day, the Protein G beads were washed three times with RIP buffer and then incubated for 12 hours with rotation at 4C in RIP buffer
containing IMP2 peptide (Genescript). The supernatant was then mixed with magnetic Dynabeads MyOne Streptavidin C1 beads
(Invitrogen 65001), which were prewashed with PBS and RIP buffer. The following day, the streptavidin beads were three times
washed with ice-cold RIP buffer – all steps were performed in a 4C room. Samples were then incubated with Proteinase K at
55C for 30 minutes. Beads were resuspended in TRIzol, RNA extraction was performed immediately followed by cDNA synthesis
(outlined in Quantitative PCR section).
QUANTITATIVE PROTEOMICS
Bead digestion
After conducting streptavidin immunoprecipitation, streptavidin beads were snap frozen and sent to the Thermo Fisher Center for
Multiplexed Proteomics (TCMP) at Harvard Medical School. For each tandemmass tag (TMT) mass spectrometry experiment, three
biological replicates per condition were submitted.
The beads were washed three times with 50 mM Tris buffer, pH 8.0 to remove any trace of detergents and unspecific binders fol-
lowed by resuspension in 1M Urea, 50 mM Tris, pH 8.0 and initially digesting it with Trypsin (5 ng/ml) at 37C for one hour under
shaking. After initial trypsin incubation, samples were centrifuged briefly and the supernatant were collected in tubes. Beads were
further washed three times with 1M Urea, 50 mM Tris, pH 8.0 and washed fractions were pooled in the same tubes and left to digest
overnight at room temperature. The following morning, digested peptides were reduced first with 5 mM TCEP, followed by alkylation
with 10 mM Iodoacetamide, quenching alkylation with 5 mM DTT and finally quenching the digestion process with TFA. Acidified
digested peptide were desalted over C18 stagetip following protocol described before (Ong et al., 2002). Briefly, the tips were pre-
pared placing a small disc of Empore material 3M in an ordinary pipette tip, preparing a single tip for each sample. Tips were cleaned
and secured with Methanol, activated with 50% acetonitrile, 0.1% TFA, equilibrated with 0.1% TFA. Acidified digested sample was
added to the column and finally washed twice with 0.1%TFA solution. Liquid was passed through the pipette tip with a centrifugation.
Peptides were then eluted with 80% acetonitrile, 0.1% TFA buffer thrice and dried in a speedvac. Dried desalted nine peptides sam-
ples were reconstituted with 200 mM EPPS buffer, pH 8.0 and labeled with respective first 9 of a 10-plex tandem mass tag (TMT)
reagent. The 9-plex labeling reactions were performed for 1 hour at room temperature. Modification of tyrosine residues with TMT
was reversed by the addition of 5% hydroxyl amine for 15 minutes and the reaction was quenched with 0.5% TFA. Samples were
combined, further desalted over stage-tip, finally eluted into an Autosampler Inserts (Thermo Scientific), dried in a speedvac and re-
constituted with 5% Acetonitrile-5% TFA for MS analysis.
Liquid chromatorgraphy-MS3 spectrometry (LC-MS/MS)
Labeled peptide sample from the previous step was analyzed with an LC-MS3 data collection strategy (McAlister et al., 2014) on an
Orbitrap Fusion mass spectrometer (Thermo Fisher Scientific) equipped with a Thermo Easy-nLC 1200 for online sample handling
and peptide separations. Resuspended peptides from the previous step was loaded onto a 100 mm inner diameter fused-silica micro
capillary with a needle tip pulled to an internal diameter less than 5 mm. The column was packed in-house to a length of 35 cm with a
C18 reverse phase resin (GP118 resin 1.8 mm, 120 Å, Sepax Technologies). The peptides were separated using a 180 min linear
gradient from 5% to 42% buffer B (90% ACN + 0.1% formic acid) equilibrated with buffer A (5% ACN + 0.1% formic acid) at a
flow rate of 500 nL/min across the column.
The scan sequence for the FusionOrbitrap beganwith anMS1 spectrum (Orbitrap analysis, resolution 120,000, scan range of 350 -
1350 m/z, AGC target 13 106, maximum injection time 50 ms, dynamic exclusion of 90 s). The ‘‘Top10’’ precursors was selected for
MS2 analysis, which consisted of CID (quadrupole isolation set at 0.7 Da and ion trap analysis, AGC 93 103, Collision Energy 35%,
maximum injection time 80ms). The top ten precursors from eachMS2 scan were selected for MS3 analysis (synchronous precursor
selection), in which precursors were fragmented by HCD prior to Orbitrap analysis (Collision Energy 55%, max. AGC 1 3 105,
maximum injection time 120 ms, resolution 50,000 and isolation window set to 1.2 – 0.8).
LC-MS3 data analysis
A suite of in-house software tools were used for .RAW file processing and controlling peptide and protein level false discovery rates,
assembling proteins from peptides, and protein quantification from peptides. MS/MS spectra were searched using the SEQUEST
(Eng et al., 1994) algorithm against a Uniprot composite human database (human release 2017-10) with both the forward and reverse




sequences. Database search criteria are as follows: tryptic with two missed cleavages, a precursor mass tolerance of 50 ppm, frag-
ment ion mass tolerance of 1.0 Da, static alkylation of cysteine (57.02146 Da), static TMT labeling of lysine residues and N-termini of
peptides (229.162932 Da), and variable oxidation of methionine (15.99491 Da). Peptide spectral matches were filtered to a 1% false
discovery rate (FDR) using the target-decoy strategy combined with linear discriminant analysis. The proteins were filtered to a < 1%
FDR. TMT reporter ion intensities weremeasured using a 0.003Dawindow around the theoretical m/z for each reporter ion in theMS3
scan. Proteins were quantified only from peptides with a summed SN threshold of > 200 andMS2 isolation specificity of 0.5. Peptide
spectral matches with poor quality MS3 spectra were excluded from quantitation (< 200 summed signal-to-noise across 10 channels
and < 0.5 precursor isolation specificity).
Before analysis, proteins previously reported to non-specifically bind BirA* were removed (Roux et al., 2018). For analysis, TMT raw
intensity values (raw data in Table S1) underwent Log2-fold-change (L2FC) calculation and enrichment analysis. For actinin proteome
analysis (Figure 1), data from experiments 1 and 2were utilized to determine significantly enriched proteins by calculating the L2FC of
proteins from Actinin-BirA* relative to control non-BirA*. Proteins considered to be significantly enriched were those with L2FC R 1
and false discovery rate (FDR) < 0.05 (using two-way ANOVA followed by a two-stage linear step-up procedure of Benjamini, Krieger
and Yekutieli to correct for multiple comparisons (Benjamini et al., 2006)). For sarcomere assembly actinin proteome analysis (Fig-
ure S1), data from experiment 2 was similarly analyzed to first determine enriched proteins using cTnT-WT-Actinin-BirA* relative to
control non-BirA* (n = 294 hits with L2FC R 1 and FDR < 0.05). These enriched proteins were then analyzed for sarcomere-depen-
dency status by calculating the L2FC of proteins from cTnT-WT-Actinin-BirA* relative to cTnT-KO-Actinin BirA*, with significant hits
being defined as those with L2FCR 1 and FDR < 0.05 (n = 47). Additionally, Z-disk exclusive hits were those significantly enriched in
cTnT-WT-Actinin-BirA* relative to control non-BirA*, but not in the cTnT-KO-Actinin-BirA* relative to control non-BirA* (n = 24 hits with
L2FCR 1 and FDR < 0.05). For visualization of data, Search Tool for the Retrieval of Interacting Genes/Proteins (STRING v. 11.0) was
utilized for generation of interaction scores (proteins were not distinguished by isoform). Cytoscape (v.3.7.2) was utilized to generate
interaction maps with an organic layout and the utilization of the CLUSTER and BINGO features for group clustering and appropriate
GO term identification for each cluster. Quantitative proteomics data deposited to the ProteomeXchange Consortium identifier
PXD018040.
Quantitative PCR, RNA sequencing, and analysis
cDNA was synthesized using Superscript III First-Strand synthesis (Invitrogen 18080-400). Gene-specific PCR primers were de-
signed or identified from the literature and transcripts were quantified using Fast SYBR Green (Applied Biosystems 4385612) on a
ViiA7 Real-Time PCR system (Applied Biosystems).
RNA Samples were sent for sequencing at the University of Connecticut Institute for Systems Genomics. RNA sequencing libraries
were generated using Illumina TruSeq Stranded Total RNA library preparation (Ribo-Zero depletion for rRNA was utilized for RIP-
seq). Illumina NextSeq 500/550 sequencing was conducted with the v2.5 300 cycle reagent kit 9 (High Output). Estimated total single
end reads per sample = 30-35M 150bp PE reads. Samples sequences were aligned with STAR to the hg38 human genome. In order
to look at differential expression, DESeq2 (Bioconductor) was utilized. Gene Set Enrichment Analysis (GSEA) was utilized to deter-
mine GO terms for datasets. Top 10 GO terms are presented. Furthermore, for ETC complexes, glycolysis, and sarcomere gene
sets – GSEA gene sets were utilized and those with an average R 5 TPM value were included in the dataset. TPM (transcripts per
million) is a normalization technique for transcriptomic data to adjust for transcript count read depth and transcript length, such
that all transcript counts are normalized by transcript length and then presented as a proportion out of 1 million counts. Genome
sequencing datasets are deposited at GEO under accession numbers: GSE144806.
Protein Immunoblotting
Samples of interest were lysed in RIPA buffer (Cell Signaling 9806) containing protease inhibitor cocktail (Roche 11836170001), 1mM
PMSF, and phosphatase inhibitor (Pierce A32957), unless noted otherwise. Protein lysate concentrations were normalized using
Pierce BCA (Thermo 23225), and then reduced and denatured in sample buffer (Thermo 39000). Lysates were separated on Bio-
Rad 4%–20% Mini-PROTEAN TGX precast gels, transferred via Bio-Rad Trans-Blot Turbo onto PVDF membranes (Bio-Rad
1704272), blocked in TBS-T (TBS with 0.1% Tween-20) containing 5% BSA, and probed overnight at 4C with primary antibody.
The next day, blots were washed in TBS-T and probed with HRP-linked secondary antibody (Cell Signaling 7076; 7074; Streptavi-
din-HRP 3999S) for 1 hour. Signal detection was performed using ECL substrate (Thermo 34577; 34095) and a Bio-Rad ChemiDoc
MP imaging system. Blot imageswere digitally processed and analyzed in ImageJ. The primary antibodies usedwere as follows: anti-
actinin (isoforms 1-4) (Cell Signaling 6487), anti-HA (Cell Signaling 14793), anti-IGF2BP2 (MBL RN008P), anti-PBCBP1 (Abcam
74793), anti-PCBP2 (MBL RN250P), anti-SERBP1 (Abcam 55993), anti-TCAP (BD 612328), anti-FLAG (Cell Signaling 2368), anti-
GAPDH (Cell Signaling 2118) and anti-MYOM (mMaC myomesin B4 was deposited to the DSHB by Perriard, J.-C.).
Immunofluorescence and RNA FISH
For standard immunofluorescence images, cells were fixed on coverslips (Fisherbrand 12-545-100) in PBS containing 4% parafor-
maldehyde (EMS 50-980-487) and then permeabilized and blocked in PBS-T (PBS containing 0.1% Triton-X) with 1% BSA (Fisher
BP1605100). Cells were probed with primary antibody in PBS-T with BSA overnight at 4C. The following primary antibodies were
used:, anti-Actinin (Sigma A7811), anti-IGF2BP2 (Bethyl A303-316A), and anti-FLAG (Cell Signaling 2368). The next day coverslips




were washed in PBS-T, incubated for 1 hour at room temperature with 1 mg/mL DAPI (Invitrogen D1306) and appropriate secondary
antibody (Invitrogen A-11005 or A-11008) or streptavidin-488 (Invitrogen S11223), washed, and mounted onto slides (Corning 2948)
in ProLong Diamondmountant (Invitrogen P36965). An Andor Dragonfly 500 confocal microscope system using a Zyla sCMOS cam-
era and a Leica DMi8 63x oil immersion lens was used for imaging slides. Andor Fusion software was used to acquire images, which
were converted to OME-TIFF format using Bitplane Imaris and analyzed in ImageJ.
ViewRNA direct fluorescence RNA in situ hybridization was conducted using the manufacturer’s protocol (Invitrogen 19887). The
following human probes were utilized: NDUFA1 (Invitrogen VA6-3172657), NDUFA8 (Invitrogen VA1-3003564), TTN (Invitrogen VA6-
3173894), HIST1H1E (Invitrogen VA6-3172001), and HRC (Invitrogen VA6-3172126). Final step of coverslip mounting and image
acquisition are described above. For distance quantification, Imaris software was utilized. Images first underwent background sub-
traction to minimize background signal and allow for clear puncta visualization. The distance transformation tool on Imaris was used
to quantify distance (in microns) of RNA puncta and actinin structures.
Mammalian-Two Hybrid
Actinin (full-length and domains), IGF2BP2 (full-length and domains), PCBP1, PBCBP2, and SERBP1 were amplified from human
cDNA and cloned into the appropriate vectors (pACT or pBIND) provided by the CheckMate Mammalian Two-Hybrid kit (Promega
E2440). To generate mutant variants of actinin, variant-specific mutagenic primers were designed (Agilent QuikChange) and paired
with universal primers specific to pACT or pBIND vectors, such that PCR amplification would generate a mutant actinin split into two
PCR fragments at the point of the mutation (sequences in Table S3). This strategy enables the use of a single, three-fragment Gibson
Assembly reaction, avoiding potential polymerase errors that may go un-sequenced in classical PCR mutagenesis involving ampli-
fication of the entire backbone. The appropriate combination of edited pACT and pBIND vectors, in addition to the kit-provided
pGluc5 vector, were transfected using PEI into HEK293T cells (ATCC CRL-3216), as outlined in the manufacturer’s protocol. In addi-
tion, the kit-provided positive and negative controls were transfected simultaneously for all experiments to verify proper signal pro-
duction. Luciferase and Renilla activity were measured using manufacturer’s protocol (Promega E1910) utilizing BioTek’s Synergy 2
multi-mode microplate reader.
PyMOL Molecular Viewer
PyMOL version 2.4.0 was utilized to generate figures illustrating actinin’s ribbon structure and the plugin ‘‘APBS Electrostatics’’ was
used to visualize electrostatic surfaces. The coordinates of the crystal structure of actinin’s rod domain were found on the Protein
Data Bank (PDB ID: 1HCI). Protein structures were exported from PyMOL and presented in figures.
Lentivirus Production
HEK293T cells (ATCCCRL-3216) were seeded onto 150mmplates in 20mLDMEM (GIBCO 11965092) supplementedwith 10%FBS
(Gemini 100-106), GlutaMAX (GIBCO 35050061), and 1 mM sodium pyruvate (GIBCO 11360070). HEK293T cells were transfected
with 18ug of lentiviral transfer vector, 12 mg psPAX2 (Addgene 12260), and 6 mg pCMV-VSV-G (Addgene 8454) (Stewart et al.,
2003). Media was replenished the following day and virus-containing media was harvested at 48, 72, and 96 hours post-transfection,
followed by concentration using PEG-6000 as previously described (Kutner et al., 2009). For titer determination - iPSCs were trans-
duced with a serial dilution of lentivirus, followed by treating with appropriate antibiotic (1mg/ml puromycin), and counting resistant
colony-forming units.
Individual Gene Knockdown and Overexpression Constructs
Lentiviral-based hairpins or overexpression constructs were transduced into iPSC-CMs at a MOI of 2 in RPMI-B27 (Sarbassov et al.,
2005). Media was replenished the following day and cells were analyzed 7-10 days post transduction.
His Protein Interaction Pull-Down
For generation of bait bacterial expression vector, actinin (WT or E445A) was cloned into pNIC28-Bsa4 (Addgene 26103) (Savitsky
et al., 2010). Vectors were transformed into BL21 (DE3) competent E. coli (NEB C2527I). A single colony was resuspended in 5 mL
liquid culture with antibiotic and incubated at 37C until OD600 reached 0.4-0.8. At this point IPTG (ThermoFisher R1171) induction at
final concentration of 500 mM was begun for 4 hours at 37C. For bait preparation, protocol from Pierce Pull-Down PolyHis Protein:
Protein Interaction Kit (ThermoFisher 21277) was followed. Prey protein was prepared from day 30 iPSC-CMs. Pull-down was con-
ducted using instructions and reagents provided in Pierce Pull-Down PolyHis Protein:Protein Interaction Kit (ThermoFisher 21277).
Protein concentration of bait protein lysates were determined using BCA (ThermoFisher 23225) and equal amount of protein was
loaded into columns for each condition.
OCR measurements using Seahorse
30,000 wild-type CMs were plated on Seahorse XFe96 Cell Culture Microplates (Agilent 101085-004) and lentiviral overexpression
constructs (Actinin-WT or Actinin-E445A; cTnT-WT or cTnT-R92Q) were added the next day. The cells were cultured for 7 days
before performing the Seahorse XF Cell Mito Stress Test (Agilent 103015-100) according to manufacturer’s protocol. The following
final concentrations of compounds were injected: oligomycin (1 mM), FCCP (1 mM), and rotenone/antimycin A (0.5 mM).




Cardiac microtissue (CMT) assay
CMTs were generated as previously described (Cohn et al., 2019; Hinson et al., 2015). Briefly, polydimethylsiloxane (PDMS) (Corning
Sylgard 184) cantilever devices were molded from SU-8 masters, which were embedded with fluorescent microbeads (Thermo
F8820). Singularized iPSC-CMs were mixed with human cardiac fibroblasts and spun into PDMS devices containing a collagen-
based ECM. For overexpression experiments, lentivirus was added to iPSC-CMs 7 days prior to generation of CMTs. CMT function
wasmeasured once tissues compacted and were visibly pulling the cantilevers. For acquisition of functional data, tissues were stim-
ulated at 1 Hz with a C-Pace EP stimulator (IonOptix) with platinumwire electrodes and fluorescence images were taken at 25 Hzwith
a Andor Dragonfly microscope equipped with enclosed live-cell chamber (Okolabs). Displacement of fluorescent microbeads was
tracked using the ImageJ ParticleTracker plug-in and twitch force was calculated. The cantilever spring constants were determined
using the elastic modulus of PDMS and the dimensions of the tissue gauge devices previously described (Boudou et al., 2012).
LDH Release Cytotoxicity Assay
Wild-type CMs were plated and lentiviral overexpression constructs (Actinin-WT or Actinin-E445A + cTnT-WT or cTnT-R92Q) were
added the next day. The cells were cultured for 7 days before being switched to glucose-free media (GIBCO 11966025) supple-
mented with 10 mM galactose (Sigma 59234). Media was collected and replenished on day 0, 1, 3, and 5. Cytotoxicity was deter-
mined utilizing LDH toxicity assay kit (ThermoFisher C20300).
QUANTIFICATION AND STATISTICAL ANALYSIS
Obtained data were analyzed and visualized using Microsoft Excel, GraphPad Prism or R. Data are presented as mean ± standard
error of the mean (SEM) unless otherwise noted. Statistical comparisons were conducted as described in the text or figure legends.
Statistical significance was defined by p % 0.05 (*), p % 0.01 (**), p % 0.001 (***), and p % 0.0001 (****) unless otherwise stated.
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